One of the BIG plus of AC8 was Canopy's backing..... seems like the only thing for shareholders to look forward to is the announcement of clinical trials... that is... if they are successful. If it fails.... well.. its just a shell company with a cash hoard.
Such a shame to see this company where it is right now from IPO.
where to next?, page-1622
-
- There are more pages in this discussion • 194 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)